secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001193125-23-155416
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma stockholders elect Lubner and Resnick as Class II directors, ratify EY as auditor
--------------------------------------------------------------------------------

- David C. Lubner elected with 53,754,258 votes for, 45,048 withheld (4,500,866 broker non-votes).
- Joshua Resnick, M.D. elected with 44,270,251 votes for, 9,529,055 withheld (4,500,866 broker non-votes).
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 58,294,758 for, 1,908 against, 3,506 abstentions.
- Approximately 87% of outstanding shares (58.3M) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312523155416/0001193125-23-155416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312523155416/d436577d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-155416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer